Crescita Therapeutics Inc T.CTX

Alternate Symbol(s): CRRTF

Healthcare

Crescita Therapeutics Inc. is a commercial dermatology company with in-house research and development (R&D) and manufacturing capabilities. It offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. It operates in three segments: Commercial Skincare, Licensing and Royalties and Manufacturing and Services. The Commercial Skincare segment manufactures and sells branded non-prescription skincare products for the Canadian and international markets. It also commercializes Pliaglis, NCTF Boost 135 HA, ART FILLER and Obagi Medical in Canada. The Licensing and Royalties segment engaged in licensing the intellectual property related to Pliaglis or its transdermal delivery technologies. Manufacturing and Services segment engaged in the sale of topical products manufactured to client specifications under the Company’s contract development and manufacturing organization infrastructure, and sales of product development services.

TSX:CTX - Post by User

Crescita Therapeutics Inc > Trading below cash value

<< Previous

Bullboard Posts

Next >>

Comment by matt2018on Dec 24, 2021 1:34pm

219 Views

Post# 34261299

RE:RE:RE:RE:Trading below cash value

recently announced another bid to where the company "intends" to purchase 1M shares over the next year.
Great idea, they have the cash on hand, now go out and execute it.
At todays prices would cost less than $700,000. Even if final cost is $1M, its a good use of the cash.
Last yeat they anounced same plan and purchased appr $90,000 worth of stock. In a whole year! What a joke!

<< Previous

Bullboard Posts

Next >>

Is China getting serious? Rheinmetall and Almonty Industries profit